These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30324343)

  • 21. Efficacy of fluoropyrimidine-based chemotherapy in patients with advanced biliary tract cancer after failure of gemcitabine plus cisplatin: retrospective analysis of 321 patients.
    Kim BJ; Yoo C; Kim KP; Hyung J; Park SJ; Ryoo BY; Chang HM
    Br J Cancer; 2017 Feb; 116(5):561-567. PubMed ID: 28081540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.
    Fornaro L; Cereda S; Aprile G; Di Girolamo S; Santini D; Silvestris N; Lonardi S; Leone F; Milella M; Vivaldi C; Belli C; Bergamo F; Lutrino SE; Filippi R; Russano M; Vaccaro V; Brunetti AE; Rotella V; Falcone A; Barbera MA; Corbelli J; Fasola G; Aglietta M; Zagonel V; Reni M; Vasile E; Brandi G
    Br J Cancer; 2014 Apr; 110(9):2165-9. PubMed ID: 24714745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis.
    Ji JH; Kim YS; Park I; Lee SI; Kim RB; Park JO; Oh SY; Hwang IG; Jang JS; Song HN; Kang JH
    Cancer Res Treat; 2018 Jul; 50(3):791-800. PubMed ID: 28838033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
    Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
    Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study.
    Nie C; Lv H; Xing Y; Chen B; Xu W; Wang J; Chen X
    BMC Cancer; 2021 Feb; 21(1):189. PubMed ID: 33622272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
    Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
    Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
    Kang J; Lee SH; Son JH; Lee JW; Choi YH; Choi JH; Paik WH; Ryu JK; Kim YT
    PLoS One; 2018; 13(4):e0195118. PubMed ID: 29608578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of first-line chemotherapy affects the second-line setting response in patients with advanced non-small cell lung cancer.
    Cao W; Li AW; Ren SX; Chen XX; Li W; Gao GH; He YY; Zhou CC
    Asian Pac J Cancer Prev; 2014; 15(16):6799-804. PubMed ID: 25169528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes with second-line chemotherapy in advanced pancreatic cancers: A retrospective study from a tertiary cancer center in India.
    Ramaswamy A; Parthiban S; Malhotra M; Kothari R; Goel A; Bhargava P; Srinivas S; Kulkarni S; Ostwal V
    Indian J Cancer; 2018; 55(2):144-147. PubMed ID: 30604725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes and patterns of secondary relapse in platinum-sensitive ovarian cancer: implications for tertiary cytoreductive surgery.
    Tang J; Liu DL; Shu S; Tian WJ; Liu Y; Zang RY
    Eur J Surg Oncol; 2013 Jul; 39(7):786-91. PubMed ID: 23490332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials.
    McNamara MG; Bridgewater J; Lopes A; Wasan H; Malka D; Jensen LH; Okusaka T; Knox JJ; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; Valle JW
    BMC Cancer; 2017 Apr; 17(1):262. PubMed ID: 28403829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
    Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
    Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma.
    Kim JH; Do IG; Kim K; Sohn JH; Kim HJ; Jeon WK; Lee SR; Son BH; Shin JH; Nam H; Kwon HJ; Kim MS; Hong HP; Serrero G; Koo DH;
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):1085-1092. PubMed ID: 27744566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
    Fanotto V; Cordio S; Pasquini G; Fontanella C; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Torri V; Aprile G
    Gastric Cancer; 2017 Sep; 20(5):825-833. PubMed ID: 28028664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
    Ji JH; Song HN; Kim RB; Oh SY; Lim HY; Park JO; Park SH; Kim MJ; Lee SI; Ryou SH; Hwang IG; Jang JS; Kim HJ; Choi JY; Kang JH
    Jpn J Clin Oncol; 2015 Mar; 45(3):256-60. PubMed ID: 25628352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy.
    Lamarca A; Rigby C; McNamara MG; Hubner RA; Valle JW
    World J Gastroenterol; 2016 Jul; 22(26):6065-75. PubMed ID: 27468198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and prognostic factors of 178 advanced non-small lung cancer patients undergoing different second-line chemotherapeutic regimens].
    Kong Q; Wang XY; Jiang RC; Ba Y; Li K
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):294-9. PubMed ID: 27087377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic impact of differentiation at the invasive front of biliary tract cancer.
    Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M
    J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.